<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d239">
    <sentence id="DDI-DrugBank.d239.s0" text="No trials specifically examining potential drug interactions with Natrecor were conducted, although many concomitant drugs were used in clinical trials.">
        <entity id="DDI-DrugBank.d239.s0.e0" charOffset="66-73"
            type="brand" text="Natrecor"/>
    </sentence>
    <sentence id="DDI-DrugBank.d239.s1" text="No drug interactions were detected except for an increase in symptomatic hypotension in patients receiving oral ACE inhibitors.">
        <entity id="DDI-DrugBank.d239.s1.e0" charOffset="112-125"
            type="group" text="ACE inhibitors"/>
    </sentence>
    <sentence id="DDI-DrugBank.d239.s2" text="The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).">
        <entity id="DDI-DrugBank.d239.s2.e0" charOffset="25-32"
            type="brand" text="Natrecor"/>
        <entity id="DDI-DrugBank.d239.s2.e1" charOffset="42-53"
            type="group" text="vasodilators"/>
        <entity id="DDI-DrugBank.d239.s2.e2" charOffset="63-75"
            type="drug" text="nitroglycerin"/>
        <entity id="DDI-DrugBank.d239.s2.e3" charOffset="78-90"
            type="drug" text="nitroprusside"/>
        <entity id="DDI-DrugBank.d239.s2.e4" charOffset="93-101"
            type="drug" text="milrinone"/>
        <entity id="DDI-DrugBank.d239.s2.e5" charOffset="110-123"
            type="group" text="ACE inhibitors"/>
        <entity id="DDI-DrugBank.d239.s2.e6" charOffset="191-198"
            type="brand" text="Natrecor"/>
    </sentence>
</document>
